Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)
Close on Nov 18, 2026Market cap $140.15MP/E –Yield –
Drugs Made In America Acquisition II market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Drugs Made In America Acquisition II's market cap was $140.29M on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $140.29M | -9.0% |
| 2025 | Dec 31, 2025 | $154.19M | – |
See a number that looks wrong?